Cas:28583-62-2 N-(4-butanoyl-3-hydroxyphenyl)acetamide manufacturer & supplier

We serve Chemical Name:N-(4-butanoyl-3-hydroxyphenyl)acetamide CAS:28583-62-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(4-butanoyl-3-hydroxyphenyl)acetamide

Chemical Name:N-(4-butanoyl-3-hydroxyphenyl)acetamide
CAS.NO:28583-62-2
Synonyms:N-(4-butyryl-3-hydroxyphenyl)acetamide;acetic acid-(3-hydroxy-4-butyryl-anilide);N-[3-hydroxy-4-(1-oxobutyl)phenyl]acetamide;Essigsaeure-(3-hydroxy-4-butyryl-anilid);N1-(4-butyryl-3-hydroxyphenyl)acetamide
Molecular Formula:C12H15NO3
Molecular Weight:221.25200
HS Code:2924299090

Physical and Chemical Properties:
Melting point:85ºC
Boiling point:431.9ºC at 760mmHg
Density:1.192g/cm3
Index of Refraction:1.579
PSA:66.40000
Exact Mass:221.10500
LogP:2.40640

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(4-butyryl-3-hydroxyphenyl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N1-(4-butyryl-3-hydroxyphenyl)acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-[3-hydroxy-4-(1-oxobutyl)phenyl]acetamide Use and application,Essigsaeure-(3-hydroxy-4-butyryl-anilid) technical grade,usp/ep/jp grade.


Related News: You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs. N-(4-butanoyl-3-hydroxyphenyl)acetamide manufacturer Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations. N-(4-butanoyl-3-hydroxyphenyl)acetamide supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. N-(4-butanoyl-3-hydroxyphenyl)acetamide vendor The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. N-(4-butanoyl-3-hydroxyphenyl)acetamide factory Chung also said South Korean citizens who had visited the province in the past 14 days should voluntarily quarantine themselves at home for two weeks after they arrive back into the country.